DIA 2013 49th Annual Meeting
Click here to go to the previous page
Coalition for Accelerating Standards and Therapies (CFAST): The Ultimate Drug Development Drivers
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 346
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 252AB
CHAIR :
 Rebecca D. Kush, PhD (SCHNON), President and CEO, CDISC, United States
SPEAKER (S):
 David C. Jordan, PhD,MSc (SPKNON), Leader, Data Standards Project, TransCelerate Biopharma Inc., United States
 Brian Harvey, MD (SPKNON), Vice President, US Regulatory Strategy, Pfizer Inc, United States
 Ron Fitzmartin, PhD,MBA (SPKAGY), Senior Advisor, Data Standards Program, Office of Strategic Programs, CDER, FDA, United States
Description
The Coalition for Accelerating Standards and Therapies (CFAST) was formed by the Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) "to accelerate clinical research and medical product development by creating and maintaining data standard, tools and methods for conducting research in therapeutic areas that are important to public health." CFAST was officially launched in October 2012. This session will focus on CFAST activities, specifically the development of data standards and the implementation of these standards to accelerate the development and review of new therapies and to enhance the information that can be obtained from streamlining the sharing, aggregation and analysis of clinical research data. CFAST is working with FDA, TransCelerate, the Innovative Medicines Initiative (IMI), ACRES, other partners and countless volunteers in this endeavor.